Afya Limited (NASDAQ:AFYA - Get Free Report) declared a -- dividend on Thursday, March 13th, NASDAQ Dividends reports. Shareholders of record on Wednesday, March 26th will be given a dividend of 0.232 per share on Friday, April 4th. The ex-dividend date is Wednesday, March 26th.
Afya has a dividend payout ratio of 12.4% indicating that its dividend is sufficiently covered by earnings. Analysts expect Afya to earn $1.91 per share next year, which means the company should continue to be able to cover its $0.23 annual dividend with an expected future payout ratio of 12.0%.
Afya Stock Performance
Shares of NASDAQ AFYA traded down $0.13 during mid-day trading on Friday, reaching $17.87. 83,363 shares of the company's stock were exchanged, compared to its average volume of 122,905. The firm has a 50-day moving average price of $16.97 and a two-hundred day moving average price of $16.53. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.60 and a quick ratio of 1.60. The firm has a market capitalization of $1.67 billion, a price-to-earnings ratio of 14.41, a price-to-earnings-growth ratio of 0.29 and a beta of 0.82. Afya has a 52 week low of $14.52 and a 52 week high of $20.06.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on AFYA. Citigroup reissued a "sell" rating and set a $15.00 target price (down from $18.00) on shares of Afya in a research report on Friday, January 31st. JPMorgan Chase & Co. decreased their target price on Afya from $25.00 to $20.50 and set a "neutral" rating for the company in a research report on Friday, January 17th. Morgan Stanley cut Afya from an "equal weight" rating to an "underweight" rating and dropped their price target for the company from $19.00 to $17.00 in a research report on Tuesday, March 11th. Finally, The Goldman Sachs Group initiated coverage on Afya in a report on Tuesday, December 3rd. They issued a "sell" rating and a $16.00 price objective for the company. Three equities research analysts have rated the stock with a sell rating and two have assigned a hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Reduce" and a consensus target price of $17.60.
View Our Latest Research Report on Afya
About Afya
(
Get Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Recommended Stories
Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
